Experimental Molecule 'Reprograms' Brain's Immune Defense Against Alzheimer's

Researchers have discovered an experimental compound called OLE that can reprogram brain immune cells to restore their protective function against Alzheimer's disease. The molecule helps microglia cells enclose and contain beta-amyloid plaques, reducing their size and toxicity. Published in Cell Death and Disease, this finding represents a promising approach to slowing neurodegeneration by enhancing the brain's natural defense mechanisms. If validated in further studies, OLE could offer new therapeutic options for Alzheimer's patients who currently have limited treatment choices.

Originally published on
Medical Xpress
Read full article(opens in new tab)Fetched: June 2, 2026 at 10:11 AM



